VetFluid

Antibiotic Therapy

Amoxicillin/Clavulanate

Beta-lactamase-inhibitor-potentiated aminopenicillin · bactericidal (cell-wall synthesis inhibitor)

Species: Dogs & Cats11 dose protocols9 dosage forms

This page is a calculation and educational reference for veterinarians and veterinary students. It does not replace examination, culture and susceptibility testing, clinical judgment, or the attending veterinarian's final decision.

Drug overview

Beta-lactamase-inhibitor-potentiated aminopenicillin · bactericidal (cell-wall synthesis inhibitor)

General dose: 10–20 mg/kg PO · every 12 hSource: Current veterinary product labels

Spectrum of activity

A broad-spectrum, bactericidal aminopenicillin; adding clavulanic acid (a beta-lactamase inhibitor) makes it active against beta-lactamase-positive staphylococci and anaerobes (including Bacteroides). Its spectrum covers Gram-positives (staphylococci, streptococci, enterococci, Listeria, Actinomyces), many Gram-negatives (Pasteurella, E. coli, Proteus, Haemophilus) and spirochetes (Borrelia of Lyme disease, Leptospira). But it has no activity against Pseudomonas, Enterobacter, Serratia and methicillin-resistant staph (MRSA/MRSP); and because its mechanism is cell-wall inhibition, it has no effect on cell-wall-free (Mycoplasma) or intracellular (Rickettsia, Ehrlichia, Chlamydia) bacteria.
Amoxicillin/Clavulanate spectrum of activity chart
Open the full-size spectrum image

Veterinary uses and doses

General (susceptible) infection

DogSource: Plumb's

11 mg/kg · every 12 h

CatSource: Plumb's

Cat: 10 mg/kg · every 12 h

Urinary tract infection (UTI)

DogSource: ISCAID 2019

10 mg/kg · every 12 h · 3–5 days

Clinical note: For sporadic cystitis, plain amoxicillin is first-line (ISCAID 2019); reserve co-amoxiclav for recurrent/complicated infection or beta-lactamase-producing bacteria.
CatSource: ISCAID 2019

Cat: 10–20 mg/kg · every 12 h · 3–5 days

Clinical note: For sporadic cystitis, plain amoxicillin is first-line and co-amoxiclav is reserved for recurrent/complicated or beta-lactamase-positive cases (ISCAID 2019). In cats most lower-urinary signs are idiopathic (FIC) and non-infectious — confirm infection by culture before giving an antibiotic.

Skin & soft tissue

DogSource: Plumb's

Soft tissue/skin: 10 mg/kg · every 12 h · 5–7 days

DogSource: Plumb's

Deep pyoderma: 10 mg/kg · every 12 h · 14–120 days

DogSource: Aucoin 2002

Non-superficial pyoderma: 10–20 mg/kg · every 12 h · 3–6 weeks

Clinical note: Maximum 520 mg of amoxicillin per dose (equivalent to 650 mg of a 4:1 product). If no response by the end of the first week, increase to three times daily; and if there is still no response by the end of the second week, stop treatment.
DogSource: Hillier 2006

Recurrent pyoderma: 11–17.5 mg/kg · every 8–12 h

CatSource: Greene 2006

Cat: 10–20 mg/kg · every 12 h · 5–7 days

Sepsis / bacteremia

DogSource: Plumb's

Bacteremia (oral step-down): 17.5 mg/kg · every 8–12 h · 7 days

Clinical note: ⚠️ Active sepsis/bacteremia requires initial intravenous therapy. Oral co-amoxiclav is not adequate for a septic patient; this dose is only for oral step-down after the patient is stabilized.
CatSource: Greene 2006

Cat — bacteremia/pneumonia (oral step-down): 10–20 mg/kg · every 8 h · 7–10 days

Clinical note: ⚠️ Active sepsis/bacteremia requires initial intravenous therapy. Oral co-amoxiclav is not adequate for a septic patient; this dose is only for oral step-down after the patient is stabilized.

Dosage forms

Safety and clinical notes

Cited sources

  1. Current veterinary product labels
  2. Plumb's
  3. ISCAID 2019
  4. Aucoin 2002
  5. Hillier 2006
  6. Greene 2006
Calculate a weight-based dose

Drug-data last updated: